Correlation between alteration of MFAP5 level and improvement of clinical indicators in patients with overweight polycystic ovary syndrome treated with metformin combined with liraglutide

Correlation between alteration of MFAP5 level and improvement of clinical indicators in patients with overweight polycystic ovary syndrome treated with metformin combined with liraglutide

Objective To explore the role and underlying mechanism of microfibrillar associated protein 5 (MFAP5) in the treatment of overweight polycystic ovary syndrome (PCOS) with metformin combined with glucagon-like peptide-1 receptor agonist (GLP-1RA), liraglutides, by analyzing the correlation of the mo...

Full description

Bibliographic Details
Main Authors: LI Weixin, LI Xing, LIAO Mingyu, SHI Liu, ZHANG Yuling, PENG Guiliang, HONG Pian, LONG Min, ZHENG Hongting
Format: Article
Language:zho
Published: Editorial Office of Journal of Third Military Medical University 2022-02-01
Series:Di-san junyi daxue xuebao
Subjects:
metformin
glucagon-like peptide-1 receptor agonist
liraylutide
overweight polycystic ovary syndrome
glucolipid metabolisim
microfibrillar associated protein 5
Online Access:http://aammt.tmmu.edu.cn/Upload/rhtml/202109129.htm

Similar Items

Similar Items